Perturbations in the T cell receptor β repertoire during malaria infection in children: A preliminary study

Augustina Frimpong1,2,3, Michael Fokuo Ofori1,2, Abdoelnaser M Degoot4

  • 1West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry, Cell, and Molecular Biology, University of Ghana, Accra, Ghana.

Frontiers in Immunology
|October 31, 2022
PubMed

Insights

Malaria infection alters the T cell repertoire in children. Symptomatic malaria patients show reduced T cell receptor diversity and unique antigen specificities, impacting adaptive immunity.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Genomics

Background:

  • The T cell repertoire's changes during clinical malaria in children are largely unknown.
  • Understanding these changes is crucial for developing effective malaria interventions.

Purpose of the Study:

  • To investigate the T cell repertoire alterations in African children during Plasmodium falciparum infection.
  • To test if clonotypic expansions during malaria generate a unique T cell repertoire for each disease state.

Main Methods:

  • Sequencing of complementarity-determining region 3 (CDR3) of the TCRβ chain.
  • Comparative analysis of T cell receptor sequences from children with asymptomatic, uncomplicated, severe malaria, and healthy controls.
  • Clustering of TCR sequences based on predicted antigen specificities.

Main Results:

  • Children with symptomatic malaria exhibited lower TCR diversity and fewer shared TCR sequences than asymptomatic children.
  • TCR diversity was inversely correlated with parasite levels (parasitemia).
  • A specific TCR sequence cluster, characterized by a 4-mer amino acid motif, was overrepresented in asymptomatic individuals.

Conclusions:

  • Plasmodium falciparum infection significantly alters the T cell repertoire in children.
  • Antigen exposure during malaria disrupts the adaptive immune response.
  • Identified TCR motifs may represent key antigenic targets for future vaccine and therapeutic development.